{
 "name": "台睿",
 "slug": "tw-6580",
 "aliases": [
  "台睿生物科技股份有限公司",
  "TaiRx",
  "6580"
 ],
 "ticker": "6580",
 "industry": "生技醫療業",
 "website": "https://www.trx.com.tw/",
 "summary": "台睿（6580）是興櫃的生技醫療類股公司，2011 年成立，2017 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "台睿生物科技股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "TaiRx",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2017-06-20",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2011-08-22",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "林羣",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "簡督憲",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 1121199080,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "勤業眾信聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "https://www.trx.com.tw/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "管線：TRX-920（SN-38口服凝膠）",
   "value": "晚期實體腫瘤｜第I期、招募中｜台灣",
   "unit": "",
   "as_of": "2026-04-13",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT06143774",
   "note": "NCT06143774；ClinicalTrials.gov最後公開更新 2026-04-13；登錄狀態 RECRUITING。"
  },
  {
   "claim": "催化劑：TRX-920",
   "value": "NCT06143774主要完成日（登錄估計）｜2026-12-31（公司登錄預估）｜已公告",
   "unit": "",
   "as_of": "2026-04-13",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT06143774",
   "note": "NCT06143774；由試驗主辦方登錄的Estimated Primary Completion Date，並非解盲、核准或已完成。"
  },
  {
   "claim": "管線：CVM-1118（foslinanib）",
   "value": "中期肝細胞癌、合併sintilimab及TACE｜第IIa期、招募中｜中國",
   "unit": "",
   "as_of": "2026-07-23",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT07521852",
   "note": "NCT07521852；ClinicalTrials.gov最後公開更新 2026-07-23；登錄狀態 RECRUITING。"
  },
  {
   "claim": "催化劑：CVM-1118",
   "value": "NCT07521852主要完成日（登錄估計）｜2027-12-31（公司登錄預估）｜已公告",
   "unit": "",
   "as_of": "2026-07-23",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT07521852",
   "note": "NCT07521852；由試驗主辦方登錄的Estimated Primary Completion Date，並非解盲、核准或已完成。"
  },
  {
   "claim": "管線：CVM-1118（foslinanib）",
   "value": "不可切除晚期肝細胞癌、合併nivolumab｜第II期、招募中｜台灣",
   "unit": "",
   "as_of": "2026-04-13",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT05257590",
   "note": "NCT05257590；ClinicalTrials.gov最後公開更新 2026-04-13；登錄狀態 RECRUITING。"
  },
  {
   "claim": "催化劑：CVM-1118",
   "value": "NCT05257590主要完成日（登錄估計）｜2026-12-31（公司登錄預估）｜已公告",
   "unit": "",
   "as_of": "2026-04-13",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT05257590",
   "note": "NCT05257590；由試驗主辦方登錄的Estimated Primary Completion Date，並非解盲、核准或已完成。"
  },
  {
   "claim": "管線：CVM-1118（foslinanib）",
   "value": "晚期神經內分泌腫瘤｜第II期、活躍但不再招募（2025-12-23登錄）｜台灣",
   "unit": "",
   "as_of": "2025-12-23",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT03600233",
   "note": "NCT03600233；ClinicalTrials.gov最後公開更新 2025-12-23；登錄狀態 ACTIVE_NOT_RECRUITING。其估計結束日2026-03-31已過、登錄仍為ACTIVE_NOT_RECRUITING；不把估計日視為完成證據。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-6580.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}